|
Tel: 033-4017-0500
|
Tel: 2290-4706
|
|
|
|
Aristro Capital Markets Ltd. |
|
|
|
|
You Are On : Home | Equity |
Company Profile | Company Background
|
|
|
|
|
Company Background
|
|
Industry : Pharmaceuticals & Drugs |
House : Divis Labs |
BSE Code |
532488
|
ISIN Demat |
INE361B01024
|
Book Value (Rs.) |
488.01
|
|
NSE Code |
DIVISLAB
|
Dividend Yield % |
0.76
|
Market Cap (Rs. Mn) |
1048733.63
|
|
TTM PE (x) |
76.90
|
TTM EPS (Rs.) |
51.37
|
Face Value (Rs.) |
2
|
|
|
|
|
|
|
|
Incorporation Year
|
12-10 1990
|
Registered Office
|
1-72/23( P)/ Divis/303,Divi Towers, Cyber Hills,Gachibowli, Hyderabad, Telangana-500032 .
|
ISINNO
|
INE361B01024
|
Phone
|
040 66966300
|
E-mail
|
mail@divislabs.com |
URL
|
www.divislabs.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Ramesh BV Nimmagadda
|
Managing Director
|
Murali K Divi
|
Company Secretary
|
Satish Choudhury
|
Listing
|
BSE,NSE,MCX
|
|
|
|
|
|
|
|
|
|
|
|
|